Ledger.Open graph →
SEC Form D · filed December 26, 2013

Juno Therapeutics, Inc

Offering
$7.1M
Sold
$6.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Rick Klausner · Seattle, WADirector · PromoterChris A. Mccormack · KIRKLAND, WADirector · PromoterMatthew D. Campbell · Rancho Santa Fe, CAExec · Director · PromoterPaul M. Duncan · Arvada, COExec · Director · PromoterCatherine E. Bertazzoni · New York, NYDirector · PromoterLarry Corey · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗